DUBLIN--(BUSINESS WIRE)--The "Global Malaria Rapid Diagnostics Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The malaria rapid diagnostics devices market will register a CAGR of over 5% by 2023.
The growing incidence of malaria in countries has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and can help in better diagnosis. The number of cases of malaria is higher in Africa and Southeast Asian countries because of poverty, the lack of healthcare infrastructure, and less knowledge about parasitic infectious diseases.
The growing incidence of malaria is resulting in an increasing demand for malaria diagnostic that provide rapid results. Many countries are promoting the use of malaria rapid diagnostic products such as systems and rapid test kits to facilitate early diagnosis. Therefore, growing incidence of malaria will drive the overall market growth.
Product launches
Companies are focusing on strengthening their market positions and to expand their product portfolio by offering different types of malaria rapid diagnostic products, including assays, tests, and kits. Also, many companies are receiving pre-market approval for its product which in turn will also drive the market growth.
Inaccuracy in rapid diagnostics tests
Inaccuracy and inconsistency in rapid diagnostic test results hinder the adoption of malaria rapid diagnostic devices. The adoption of rapid diagnostic products has increased as they provide rapid test results.
However, inaccurate test results (false-negative and false-positive results) can lead to misdiagnosis and wrong treatment. Regulatory bodies have no specific guidelines on how to conduct the rapid diagnostic tests.
Competitive Landscape
The malaria rapid diagnostics devices market appears to be moderately fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Key Players
- Abbott
- bioMerieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- Consumables - Market size and forecast 2018-2023
- Systems - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- ROW - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- North America - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- Strategic alliances
- Presence of government funding and investments
- Growing demand towards non-invasive products
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- bioMerieux
- Bio-Rad Laboratories
- QIAGEN
- Sight Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/hzhhlq/malaria_rapid?w=4
